Study on the relationship between serum high density lipoprotein and Pi-deficiency syndrome in patients with coronary heart disease

Liang  Dong-hui; Chen Yun-qin; Li Zhi-liang; Li Xiao-min

doi:10.1007/s11655-007-0125-6

Your Location：

Home >

Browse articles >

Study on the relationship between serum high density lipoprotein and Pi-deficiency syndrome in patients with coronary heart disease

Updated：2021-08-27

- Study on the relationship between serum high density lipoprotein and Pi-deficiency syndrome in patients with coronary heart disease
- Chinese Journal of Integrative Medicine Vol. 13, Issue 2, Pages: 125-127(2007)
- Affiliations：
  
  Zhujiang Hospital, Nanfang Medical University,Guangzhou,China
- Author bio：
- Funds：
  
  Supported by Guangdong Provincial Natural Science Foundation (No. 06024432) and Scientific Project of Administration of Traditional Chinese Medicine of Guangdong Province (No. 2060128)
- DOI：10.1007/s11655-007-0125-6
  CLC：
- Published：2007，
Scan for full text
Liang, Dh., Chen, Yq., Li, Zl. et al. Study on the relationship between serum high density lipoprotein and Pi-deficiency syndrome in patients with coronary heart disease., Chin. J Integ. Med. 13, 125–127 (2007). https://doi.org/10.1007/s11655-007-0125-6

Liang Dong-hui, Chen Yun-qin, Li Zhi-liang, et al. Study on the relationship between serum high density lipoprotein and Pi-deficiency syndrome in patients with coronary heart disease. [J]. Chinese Journal of Integrative Medicine 13(2):125-127(2007)
Liang, Dh., Chen, Yq., Li, Zl. et al. Study on the relationship between serum high density lipoprotein and Pi-deficiency syndrome in patients with coronary heart disease., Chin. J Integ. Med. 13, 125–127 (2007). https://doi.org/10.1007/s11655-007-0125-6 DOI：

Liang Dong-hui, Chen Yun-qin, Li Zhi-liang, et al. Study on the relationship between serum high density lipoprotein and Pi-deficiency syndrome in patients with coronary heart disease. [J]. Chinese Journal of Integrative Medicine 13(2):125-127(2007) DOI： 10.1007/s11655-007-0125-6.

摘要

To explore the relationship of Pi (脾)-deficiency syndrome in TCM with the change of serum high density lipoprotein (HDL) in blood lipid metabolic disorder. Sixty-eight patients with confirmed coronary heart disease (CHD) were selected for TCM syndrome typing into Pideficiency (PD) group and non-Pi-deficiency (NPD) group. Routine blood lipids and serum lipoprotein electrophoretogram (SLPG) were determined in all patients to analyze the total content of HDL and its relative contents of sub-components HDL1–5

as well as their relation with PD syndrome. Besides

a healthy control group (62 cases) was set up. The level of serum HDL-C was lowered

SLPG abnormality rate increased in the patients with CHD

with total HDL and the relative contents of subcomponent HDL1 and HDL3 significantly lower than those in the healthy control group (P<0.01). The total HDL

HDL1 and HDL3 in the PD group were also lower than those in the NPD group (P<0.05

P<0.01). Serum HDL and its sub-components showed a definite relation with TCM PD syndrome type

therefore

further exploring the granular specificity of HDL and its sub-components as well as their influence on reverse cholesterol transport (RCT) may hopefully provide clues for developing RCT regulatory Chinese new drugs and for CHD prevention and treatment.

Abstract

as well as their relation with PD syndrome. Besides

a healthy control group (62 cases) was set up. The level of serum HDL-C was lowered

SLPG abnormality rate increased in the patients with CHD

with total HDL and the relative contents of subcomponent HDL1 and HDL3 significantly lower than those in the healthy control group (P<0.01). The total HDL

HDL1 and HDL3 in the PD group were also lower than those in the NPD group (P<0.05

P<0.01). Serum HDL and its sub-components showed a definite relation with TCM PD syndrome type

therefore

关键词

high density lipoproteincoronary heart diseasePi-deficiency syndrome

Keywords

high density lipoproteincoronary heart diseasePi-deficiency syndrome

references

Special Committee of Chinese Association of Integrative Medicine on Cardiovascular Disease. Syndrome Differentiation of Coronary Heart Disease in Traditional Chinese Medicine. Chin J Integr Tradit Chin Med 1991; 11(5): 257.

Association of Laboratory Medicine, Chinese Medical Association. Recommended method IV in blood lipid determination. Determination method of serum HDL-C (draft). Chin J Lab Med 1995; 18(5): 311–312.

Zhang M, Li XM, Yin BS, et al. Elementary observation of serum lipoprotein separation by double gradient acrylamide gel electrophoresis. J Fourth Milit Med Univ 1993; 13(S2): 535.

Zhang M, Li XM, Yin BS. Primary exploration on modified double gradient acrylamide gel electrophoresis. 1994; 19(1): 25.

Zhang M, Yin BS, editors. Therapeutics of hyperlipidemia by integrated traditional Chinese and Western medicine. Beijing: People’s Military Medical Press, 2001: 236–248.

Rye KA, Barter PJ. Formation and metabolism of prebetamigrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 2004; 24: 421–428.

Yang XJ, Zhang C, Zhao B. Clinical observation on treatment of 60 cases of hyperlipemia based on treatment of Spleen first. Beijing J Tradit Chin Med 2006; 25(1): 11–13.

Xie B. Clinical observation of 50 cases of hyperlipidemia treated by Shenling Baizhu Powder. Forum Tradit Chin Med 2000; 15(1): 31.

Cui CX, Cui CR. 168 cases of hyperlipidemia treated by principle of soothing Gan, invigorating Pi and sputum removing. Henan Tradit Chin Med 2006; 26(2): 38.

FULL TEXT LINK

More>

Views

333

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Blood stasis syndrome of coronary heart disease: A perspective of modern medicine

Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches

Study on correspondence between prescription and syndrome and the essence of phlegm and blood stasis syndrome in coronary heart disease based on metabonomics

Summary of 2011 Integrative Medical Doctors Conference

A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule (芎芍胶囊) in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patients

Related Author

No data

Related Institution

Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Academy of Chinese Medical Sciences

Department of Cardiology, Guang’anmen Hospital

Department of Integrative Cardiology, China-Japan Friendship Hospital

Guangdong Provincial Hospital of Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰